Company Filing History:
Years Active: 2020-2023
Title: Innovator Spotlight: Clayton William White
Introduction
Clayton William White is a prominent inventor based in San Francisco, California. With a focus on advancing medical therapies, he has been instrumental in developing innovative antibody technologies. His contributions to the field are marked by two notable patents that showcase his expertise and vision.
Latest Patents
Clayton holds two patents related to bispecific anti-CD3 antibodies and their applicative methods. His inventions pertain to antibodies, activatable antibodies, multispecific antibodies, and multispecific activatable antibodies that specifically bind to CD3. These inventions are significant for their potential therapeutic, diagnostic, and prophylactic applications, offering promising avenues for medical advancements.
Career Highlights
Clayton is currently affiliated with CytomX Therapeutics, Inc., where he leverages his expertise to contribute to groundbreaking biotech innovations. His work has not only enriched the company’s portfolio but has also influenced the broader field of immunotherapy and antibody research.
Collaborations
Throughout his career, Clayton has collaborated with notable colleagues including Bryan Allen Irving and Sherry Lynn La Porte. These partnerships have fostered an environment of innovation and creativity, further enhancing the impact of their collective research efforts.
Conclusion
Clayton William White's contributions to the field of antibody technology underscore the importance of innovation in medicine. With his dual patents and ongoing work at CytomX Therapeutics, he continues to push the boundaries of what is possible in therapeutic development, paving the way for future advancements in healthcare.